- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/052 - Imidazole radicals
Patent holdings for IPC class C07H 19/052
Total number of patents in this class: 69
10-year publication summary
5
|
7
|
2
|
4
|
6
|
11
|
3
|
4
|
9
|
5
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2707 |
9 |
Galecto Biotech AB | 72 |
4 |
Pacific Biosciences of California, Inc. | 759 |
4 |
Gilead Sciences, Inc. | 2032 |
3 |
University of Maryland, Baltimore County | 257 |
3 |
Bristol-myers Squibb Company | 4872 |
2 |
Alberta Health Services | 218 |
2 |
Gilead Pharmasset LLC | 40 |
2 |
The Governors of the University of Alberta | 866 |
2 |
Pericor Therapeutics, Inc. | 8 |
2 |
Risen (Suzhou) Pharma Tech Co., Ltd. | 65 |
2 |
Shanghai Junshi Biosciences Co., Ltd. | 112 |
2 |
Skylark Bioscience LLC | 4 |
2 |
The Regents of the University of California | 19859 |
1 |
Boehringer Ingelheim International GmbH | 4705 |
1 |
Agilent Technologies, Inc. | 2634 |
1 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2147 |
1 |
Asahi Kasei Kuraray Medical Co., Ltd. | 14 |
1 |
Carna Biosciences, Inc. | 61 |
1 |
Debreceni Egyetem | 48 |
1 |
Other owners | 23 |